99 related articles for article (PubMed ID: 26388189)
1. Antitumor and immunomodulatory activity of genkwanin on colorectal cancer in the APC(Min/+) mice.
Wang X; Song ZJ; He X; Zhang RQ; Zhang CF; Li F; Wang CZ; Yuan CS
Int Immunopharmacol; 2015 Dec; 29(2):701-707. PubMed ID: 26388189
[TBL] [Abstract][Full Text] [Related]
2. R-flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC(Min)/+ mouse model: implications for prophylaxis and treatment of colon cancer.
Wechter WJ; Kantoci D; Murray ED; Quiggle DD; Leipold DD; Gibson KM; McCracken JD
Cancer Res; 1997 Oct; 57(19):4316-24. PubMed ID: 9331093
[TBL] [Abstract][Full Text] [Related]
3. Palmatine from Mahonia bealei attenuates gut tumorigenesis in ApcMin/+ mice via inhibition of inflammatory cytokines.
Ma WK; Li H; Dong CL; He X; Guo CR; Zhang CF; Yu CH; Wang CZ; Yuan CS
Mol Med Rep; 2016 Jul; 14(1):491-8. PubMed ID: 27175745
[TBL] [Abstract][Full Text] [Related]
4. Antitumor Activity of Total Flavonoids from Daphne genkwa in Colorectal Cancer.
Du WJ; Yang XL; Song ZJ; Wang JY; Zhang WJ; He X; Zhang RQ; Zhang CF; Li F; Yu CH; Wang CZ; Yuan CS
Phytother Res; 2016 Feb; 30(2):323-30. PubMed ID: 26646778
[TBL] [Abstract][Full Text] [Related]
5. Krüppel-like factor 9 (KLF9) prevents colorectal cancer through inhibition of interferon-related signaling.
Brown AR; Simmen RC; Raj VR; Van TT; MacLeod SL; Simmen FA
Carcinogenesis; 2015 Sep; 36(9):946-55. PubMed ID: 26210742
[TBL] [Abstract][Full Text] [Related]
6. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis.
Chiu CH; McEntee MF; Whelan J
Cancer Res; 1997 Oct; 57(19):4267-73. PubMed ID: 9331087
[TBL] [Abstract][Full Text] [Related]
7. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA
Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of adenomatous polyposis coli-induced blockade of base excision repair pathway in colorectal carcinogenesis.
Narayan S; Sharma R
Life Sci; 2015 Oct; 139():145-52. PubMed ID: 26334567
[TBL] [Abstract][Full Text] [Related]
9. Anticancer potential of Hericium erinaceus extracts against human gastrointestinal cancers.
Li G; Yu K; Li F; Xu K; Li J; He S; Cao S; Tan G
J Ethnopharmacol; 2014 Apr; 153(2):521-30. PubMed ID: 24631140
[TBL] [Abstract][Full Text] [Related]
10. Flavones as colorectal cancer chemopreventive agents--phenol-o-methylation enhances efficacy.
Cai H; Sale S; Schmid R; Britton RG; Brown K; Steward WP; Gescher AJ
Cancer Prev Res (Phila); 2009 Aug; 2(8):743-50. PubMed ID: 19638489
[TBL] [Abstract][Full Text] [Related]
11. DRO1 inactivation drives colorectal carcinogenesis in ApcMin/+ mice.
Grill JI; Neumann J; Herbst A; Hiltwein F; Ofner A; Marschall MK; Wolf E; Kirchner T; Göke B; Schneider MR; Kolligs FT
Mol Cancer Res; 2014 Nov; 12(11):1655-62. PubMed ID: 25053805
[TBL] [Abstract][Full Text] [Related]
12. Anti-cancer, immunoregulatory, and antimicrobial activities of the frog skin host-defense peptides pseudhymenochirin-1Pb and pseudhymenochirin-2Pa.
Mechkarska M; Attoub S; Sulaiman S; Pantic J; Lukic ML; Conlon JM
Regul Pept; 2014 Nov; 194-195():69-76. PubMed ID: 25447194
[TBL] [Abstract][Full Text] [Related]
13. Liver X receptors inhibit proliferation of human colorectal cancer cells and growth of intestinal tumors in mice.
Lo Sasso G; Bovenga F; Murzilli S; Salvatore L; Di Tullio G; Martelli N; D'Orazio A; Rainaldi S; Vacca M; Mangia A; Palasciano G; Moschetta A
Gastroenterology; 2013 Jun; 144(7):1497-507, 1507.e1-13. PubMed ID: 23419360
[TBL] [Abstract][Full Text] [Related]
14. Genkwanin: An emerging natural compound with multifaceted pharmacological effects.
El Menyiy N; Aboulaghras S; Bakrim S; Moubachir R; Taha D; Khalid A; Abdalla AN; Algarni AS; Hermansyah A; Ming LC; Rusu ME; Bouyahya A
Biomed Pharmacother; 2023 Sep; 165():115159. PubMed ID: 37481929
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis.
Boolbol SK; Dannenberg AJ; Chadburn A; Martucci C; Guo XJ; Ramonetti JT; Abreu-Goris M; Newmark HL; Lipkin ML; DeCosse JJ; Bertagnolli MM
Cancer Res; 1996 Jun; 56(11):2556-60. PubMed ID: 8653697
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
[TBL] [Abstract][Full Text] [Related]
17. Haploinsufficiency of Krüppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis.
Ghaleb AM; McConnell BB; Nandan MO; Katz JP; Kaestner KH; Yang VW
Cancer Res; 2007 Aug; 67(15):7147-54. PubMed ID: 17671182
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of interferon-gamma or its receptor promotes colorectal cancer development.
Wang L; Wang Y; Song Z; Chu J; Qu X
J Interferon Cytokine Res; 2015 Apr; 35(4):273-80. PubMed ID: 25383957
[TBL] [Abstract][Full Text] [Related]
19. Stat6 activity-related Th2 cytokine profile and tumor growth advantage of human colorectal cancer cells in vitro and in vivo.
Li BH; Xu SB; Li F; Zou XG; Saimaiti A; Simayi D; Wang YH; Zhang Y; Yuan J; Zhang WJ
Cell Signal; 2012 Mar; 24(3):718-25. PubMed ID: 22108090
[TBL] [Abstract][Full Text] [Related]
20. Antitumor and immunomodulatory activity of Astragalus membranaceus polysaccharides in H22 tumor-bearing mice.
Yang B; Xiao B; Sun T
Int J Biol Macromol; 2013 Nov; 62():287-90. PubMed ID: 24060282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
